Upload Avatar (500 x 500)
Huifang Dai
Pharmaceutical Sciences
Fudan University
Shanghai
Language: English, Chinese
Green Synthesis
Industrial Applications
Heterogeneous Catalysts
Chiral Catalysis
Natural Products
Drug Discovery
Synthesis
Catalysis
Research
Development
Areas of Focus
- Research and development of green synthesis processes for industrial applications
- Design, synthesis, and research of novel heterogeneous catalysts and chiral catalytic technologies
- Research on new drug discovery based on active natural products
Work Experience
- 2009.04 – Present - Fudan University, School of Pharmacy - Lecturer in Medicinal Chemistry
- 2014.10 – Present - AuBrown PharmaTech Co. Ltd - Technical Director
- 2018.08 – Present - Jiangsu Qidong Economic and Technological Development Zone - Deputy District Chief
- 2012.06 – 2013.02 - University of California, Berkeley, Department of Chemistry/Bioenergy Institute - Research Associate III
- 2001.09 – 2003.07 - Fudan University, Department of Environmental Science - Visiting Scholar
- 1991.09 – 2001.07 - Zhejiang Jinhua Vocational and Technical College, School of Bioengineering - Lecturer
Academic Background & Achievements
- 2011.06 – 2012.06 Postdoctoral: Stanford University, Department of Chemistry
- 2011.01 – 2011.06 Postdoctoral: University of Wisconsin-Madison, School of Pharmacy
- 2004.09 – 2009.01 Ph.D. in Organic Chemistry: Fudan University, Department of Chemistry
- 1987.09 – 1991.07 Bachelor's in Chemistry: Zhejiang Normal University, Department of Chemistry
Publications
- Synthesis, structure–activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors, Xiao-Dong Ma, Qiu-Qin He, Xuan Zhang, Shi-Qiong Yang, Liu-Meng Yang, Shuang-Xi Gu, Yong-Tang Zheng, Fen-Er Chen, Hui-Fang Dai, 2012
- Asymmetric Aza-[3 t 3] Annulation in the Synthesis of Indolizidines: An Unexpected Reversal of Regiochemistry, Grant S. Buchanan, Huifang Dai, Richard P. Hsung, 2011
- Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs, Shuang-Xi Gu, Shi-Qiong Yang, Qiu-Qin He, Xiao-Dong Ma, Fen-Er Chen, Hui-Fang Dai, Erik De Clercqc, 2011
- Efficient Asymmetric synthesis of (2R,3R)-3-{(1R)-1-[tert-Butyl(dimethyl)-siloxy]ethyl}-4-oxoazetidin-2-yl Acetate, Jian-Ping Huang, Lei Zhao, Shuang-Xi Gu, Hui-Fang Dai, 2011
- Synthetic Studies on d-Biotin, Part 11): Application of Cinchona Alkaloid-Mediated Asymmetric Alcoholysis of meso-Cyclic Anhydride in the Total Synthesis of (+)-Biotin, H. F. Dai, F.E.Chen, 2008
Awards
- 2019: Commemorative Medal for the 70th Anniversary of the Founding of the People's Republic of China, Central Committee of the Communist Party of China, State Council, Central Military Commission
- 2019: Excellent Award, Jiangsu Provincial Science and Technology Town Chief Group, Jiangsu Province
- 2014: Leading Talent Honor of 'Double Dragon Talent' A-Class, Zhejiang Province
- 2010: CSC Study Abroad Fund, China Scholarship Council
- 2009: Excellent Doctoral Dissertation Award, Fudan University
- 2008: Second Prize of the 5th Shanghai Invention Patent, Shanghai
- 2007: Second Prize of National Science and Technology Progress Award (Second Place), State Council
- 2004: First Prize of Science and Technology Progress Award (Second Place), Ministry of Education
- 2003: National Excellent Teaching Paper Award, Ministry of Education
